video1.0<iframe src="https://www.loom.com/embed/1cd6a302ed0a43c595e05a1364bc2907" frameborder="0" width="1920" height="1440" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>14401920Loomhttps://www.loom.com14401920https://cdn.loom.com/sessions/thumbnails/1cd6a302ed0a43c595e05a1364bc2907-75855ea8e2737af8.gif1593.092In this presentation, I discussed Lyme disease and its post-treatment manifestations, emphasizing that this is a complex illness that can lead to persistent symptoms like fatigue, brain fog, and musculoskeletal pain in about 10-20% of treated patients. I highlighted the importance of recognizing that post-treatment Lyme disease is not a psychosomatic illness, but rather a real condition that can trigger autoimmune responses and dysautonomia. We explored the mechanisms behind these symptoms, including microbial remnants and inflammation, and identified subgroups of patients with varying symptom profiles. I also touched on the need for better treatment approaches, as there are currently no FDA-approved therapies specifically for this condition. I encourage viewers to approach patients with respect and compassion, acknowledging their experiences as valid.